Integer Holdings Corporation will host a conference call on October 23, 2025, to discuss Q3 financial results.
Quiver AI Summary
Integer Holdings Corporation will hold a conference call on October 23, 2025, at 8 a.m. CT to discuss its financial results and business highlights for the third quarter ending September 26, 2025. A news release with the financial results will be issued earlier on the same day. The call can be accessed via domestic and international dial-in numbers or through a webcast registration on their website. An audio replay will be available for seven days post-call. Integer, a leading medical device contract development and manufacturing organization, focuses on serving specific markets and enhancing patient lives with innovative products and solutions. For updates, investors can subscribe to email alerts on the company's site.
Potential Positives
- Integer Holdings Corporation will provide a webcast of its third-quarter financial results, enhancing transparency and accessibility for investors.
- The scheduled conference call allows for potential discussions on forward-looking information, indicating the company's commitment to future growth and investors' interests.
- Integer Holdings Corporation positions itself as a leader in the medical device industry, serving significant markets such as cardiac rhythm management and neuromodulation, which indicates a strong market presence and expertise.
Potential Negatives
- The timing of the earnings call may indicate potential delays or challenges in reporting financial results, sparking concerns among investors about the company’s performance.
- The mention of "forward-looking and material information" being discussed raises the possibility of negative news regarding future expectations, which could impact investor confidence.
- The reliance on a webcast and archived replays for communication may limit immediate access to information for some investors, potentially leading to misunderstandings or misinterpretations of the company's performance.
FAQ
When is Integer's Q3 2025 conference call?
Integer's Q3 2025 conference call is scheduled for Thursday, Oct. 23, 2025, at 8 a.m. CT / 9 a.m. ET.
How can I access the conference call?
You can access the conference call by dialing (800) 715-9871 for domestic calls or (646) 307-1963 for international calls.
Will there be a live webcast of the conference call?
Yes, the conference call will be available live and as an archived replay on the Investor Relations section of Integer's website.
How can I receive updates on Integer's financial news?
To receive updates on Integer's financial news, please subscribe to email alerts at investor.integer.net.
What is Integer Holdings Corporation known for?
Integer Holdings Corporation is a leading medical device contract development and manufacturing organization serving various medical markets.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$ITGR Insider Trading Activity
$ITGR insiders have traded $ITGR stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $ITGR stock by insiders over the last 6 months:
- JOSEPH W DZIEDZIC (President & CEO) has made 0 purchases and 3 sales selling 338,975 shares for an estimated $41,751,432.
- DONALD J SPENCE sold 14,739 shares for an estimated $1,774,339
- MARTIN C MAXWELL has made 0 purchases and 5 sales selling 8,720 shares for an estimated $1,051,278.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ITGR Hedge Fund Activity
We have seen 185 institutional investors add shares of $ITGR stock to their portfolio, and 185 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS removed 1,342,493 shares (-96.4%) from their portfolio in Q2 2025, for an estimated $165,086,364
- ALLIANCEBERNSTEIN L.P. added 993,810 shares (+885.1%) to their portfolio in Q2 2025, for an estimated $122,208,815
- FULLER & THALER ASSET MANAGEMENT, INC. removed 546,759 shares (-68.8%) from their portfolio in Q2 2025, for an estimated $67,234,954
- CITADEL ADVISORS LLC added 408,980 shares (+1606.4%) to their portfolio in Q2 2025, for an estimated $50,292,270
- JPMORGAN CHASE & CO added 295,364 shares (+295.6%) to their portfolio in Q2 2025, for an estimated $36,320,911
- VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. removed 282,485 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $34,737,180
- DRIEHAUS CAPITAL MANAGEMENT LLC removed 264,356 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $32,507,857
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ITGR Analyst Ratings
Wall Street analysts have issued reports on $ITGR in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 07/25/2025
- Raymond James issued a "Outperform" rating on 07/25/2025
- Wells Fargo issued a "Overweight" rating on 07/25/2025
- Citigroup issued a "Buy" rating on 05/22/2025
- Benchmark issued a "Buy" rating on 04/25/2025
- Keybanc issued a "Overweight" rating on 04/21/2025
To track analyst ratings and price targets for $ITGR, check out Quiver Quantitative's $ITGR forecast page.
$ITGR Price Targets
Multiple analysts have issued price targets for $ITGR recently. We have seen 6 analysts offer price targets for $ITGR in the last 6 months, with a median target of $140.0.
Here are some recent targets:
- Nathan Treybeck from Wells Fargo set a target price of $132.0 on 07/25/2025
- Andrew Cooper from Raymond James set a target price of $143.0 on 07/25/2025
- Richard Newitter from Truist Securities set a target price of $137.0 on 07/25/2025
- Joanne Wuensch from Citigroup set a target price of $140.0 on 05/22/2025
- Robert Wasserman from Benchmark set a target price of $140.0 on 04/25/2025
- Tim Rezvan from Keybanc set a target price of $145.0 on 04/21/2025
Full Release
PLANO, Texas, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) announced today that it will webcast its conference call discussing financial results and business highlights for the third quarter ended Sept. 26, 2025, on Thursday, Oct. 23, 2025, at 8 a.m. CT / 9 a.m. ET. Other forward-looking and material information may also be discussed during this call. The company will issue a news release announcing financial results for the third quarter on Oct. 23 prior to the conference call.
Conference call details:
- Date: Thursday, Oct. 23, 2025
- Time: 8 a.m. CT / 9 a.m. ET
- Domestic dial-in number: (800) 715-9871
- International dial-in number: (646) 307-1963
- Conference ID: 3120125
-
Webcast Registration:
ITGR Q3 2025 Earnings Call
An audio replay will be available for seven days and can be accessed by dialing (800) 770-2030 or (609) 800-9909 and using Conference ID 3120125. The conference call will also be available live or via archived replay on the Investor Relations section of the Integer website at: investor.integer.net .
From time to time, Integer posts information that may be of interest to investors on its website. To automatically receive Integer financial news by email, please visit investor.integer.net and subscribe to email alerts.
Learn more about Integer at www.integer.net .
About Integer
®
Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets. As a strategic partner of choice to medical device companies and OEMs, the Company is committed to enhancing the lives of patients worldwide by providing innovative, high-quality products and solutions. The Company's brands include Greatbatch Medical® and Lake Region Medical®. Additional information is available at
www.integer.net
.
|
Investor Relations:
Kristen Stewart [email protected] 551.337.3973 |
Media Relations:
Lauren Ban [email protected] 469.476.9615 |
